{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:18:49Z","timestamp":1783487929360,"version":"3.55.0"},"reference-count":40,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The prevalence of primary aldosteronism (<jats:styled-content style=\"fixed-case\">PA<\/jats:styled-content>) in hypertensive patients varies according to diagnostic testing and ascertained normal cut\u2010offs. The aim of this case\u2013control study was to confirm the high prevalence of <jats:styled-content style=\"fixed-case\">PA<\/jats:styled-content> in a large hypertensive population and evaluate the antihypertensive effect of mineralocorticoid receptor antagonists (<jats:styled-content style=\"fixed-case\">MRA<\/jats:styled-content>) treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>We investigated 327 hypertensive and 90 matched normotensive subjects with normal adrenal imaging. Serum aldosterone (<jats:styled-content style=\"fixed-case\">ALD<\/jats:styled-content>), active renin (<jats:styled-content style=\"fixed-case\">REN<\/jats:styled-content>) levels and aldosterone\/active renin (<jats:styled-content style=\"fixed-case\">ALD\/REN<\/jats:styled-content>) ratio were measured before and after a combined sodium chloride, fludrocortisone and dexamethasone suppression test (<jats:styled-content style=\"fixed-case\">FDST<\/jats:styled-content>). Post\u2010<jats:styled-content style=\"fixed-case\">FDST<\/jats:styled-content> values were compared to cut\u2010offs obtained from controls (post\u2010<jats:styled-content style=\"fixed-case\">FDST ALD<\/jats:styled-content> 2\u00b796\u00a0ng\/dL and post\u2010<jats:styled-content style=\"fixed-case\">FDST ALD\/REN<\/jats:styled-content> 0\u00b793\u00a0ng\/dL\/\u03bcU\/mL). <jats:styled-content style=\"fixed-case\">PA<\/jats:styled-content> patients received <jats:styled-content style=\"fixed-case\">MRA<\/jats:styled-content> treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>By applying the combination of post\u2010<jats:styled-content style=\"fixed-case\">FDST ALD<\/jats:styled-content> levels and <jats:styled-content style=\"fixed-case\">ALD\/REN<\/jats:styled-content> ratio, 28\u00b77% of the hypertensive patients had <jats:styled-content style=\"fixed-case\">PA<\/jats:styled-content>. There was a positive, albeit weak, correlation between systolic (<jats:styled-content style=\"fixed-case\">SBP<\/jats:styled-content>) and diastolic blood pressure (<jats:styled-content style=\"fixed-case\">DBP<\/jats:styled-content>) and <jats:styled-content style=\"fixed-case\">ALD<\/jats:styled-content> levels and\/or <jats:styled-content style=\"fixed-case\">ALD\/REN<\/jats:styled-content> ratio after the <jats:styled-content style=\"fixed-case\">FDST<\/jats:styled-content> (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0\u00b70001). SBP was associated with a post\u2010<jats:styled-content style=\"fixed-case\">FDST ALD<\/jats:styled-content> of 3\u00b724\u00a0ng\/dL and ALD\/REN ratio of 0\u00b790\u00a0ng\/dL\/\u03bcU\/mL, whereas post\u2010<jats:styled-content style=\"fixed-case\">FDST ALD<\/jats:styled-content> had an inverse association at serum K+ values of less than 3\u00b79\u00a0mEq\/L. <jats:styled-content style=\"fixed-case\">MRA<\/jats:styled-content> treatment in 69 <jats:styled-content style=\"fixed-case\">PA<\/jats:styled-content> patients, resulted in a significant reduction in the maximum <jats:styled-content style=\"fixed-case\">SBP<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">DBP<\/jats:styled-content> values (28\u00a0\u00b1\u00a015 and 14\u00a0\u00b1\u00a07\u00a0mmHg, respectively, <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0\u00b70001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Using the <jats:styled-content style=\"fixed-case\">FDST<\/jats:styled-content>, an increased prevalence of <jats:styled-content style=\"fixed-case\">PA<\/jats:styled-content> in hypertensives was observed. \u0391 significant blood pressure lowering effect was obtained with <jats:styled-content style=\"fixed-case\">MRA<\/jats:styled-content> treatment, implying that these agents may be beneficial in a significant number of hypertensive patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/eci.12286","type":"journal-article","created":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T08:03:38Z","timestamp":1402128218000},"page":"697-706","source":"Crossref","is-referenced-by-count":21,"title":["Primary aldosteronism in hypertensive patients: clinical implications and target therapy"],"prefix":"10.1111","volume":"44","author":[{"given":"Labrini","family":"Papanastasiou","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes Center \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Markou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Center \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Pappa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Center \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Gouli","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Center \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Tsounas","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Center \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Fountoulakis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Center \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Kounadi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Center \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Tsiama","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Center \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Dasou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Center \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Gryparis","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Epidemiology and Medical Statistics National and Kapodistrian University of Athens Medical School Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianna","family":"Samara","sequence":"additional","affiliation":[{"name":"Department of Radiology \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Zografos","sequence":"additional","affiliation":[{"name":"Third Department of Surgery \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Kaltsas","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology Laikon Hospital National and Kapodistrian University of Athens Medical School Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Chrousos","sequence":"additional","affiliation":[{"name":"First Department of Pediatrics Children's Hospital \u2018Aghia Sophia\u2019 National and Kapodistrian University of Athens Medical School Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Piaditis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Center \u2018G Gennimatas\u2019 General Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1994.tb02519.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.5.1863"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001948"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200311000-00025"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031337"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.059"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-011-9164-6"},{"key":"e_1_2_7_9_1","first-page":"57","article-title":"Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area","volume":"29","author":"Westerdahl C","year":"2011","journal-title":"Scand J Prim Health Care"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-1013"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000079505.25750.11"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001554"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2012.03.010"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70298-2"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000023182.68420.EB"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs1030425"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000230444.01215.6a"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2010.166"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3353"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0104"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0078"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02775.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2011.02531.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-19-10-1185"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.9.3141"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.07.034"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.1234"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2874"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.8.2854"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03551.x"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00464.x"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)90834-1"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.095448"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0631"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0899"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032149"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.103267"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2008.05.005"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1301281"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-013-0330-y"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033263"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Feci.12286","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/eci.12286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T10:23:29Z","timestamp":1696328609000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/eci.12286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,22]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1111\/eci.12286"],"URL":"https:\/\/doi.org\/10.1111\/eci.12286","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,22]]}}}